Table 1

Clinicopathologic and immunohistochemical characterization of MM tumors and control lung samples

CaseSexAgeStage (tumor)Histology (tumor)NOS2 (tumor)COX2 (tumor)Histology (C-1)hNOS2 (C-1)COX2 (C-1)
1M67IIIBiphasic+4a+2Normal
2M53IIIEpithelial+4+3Hb
3F63ISarcomatoid+4+2Normal
4M68IIEpithelial+4+3RMHc+3+2
5M49IIIEpithelial+3Normal
6M78IEpithelial+4+2Normal
7F48IIEpithelial+3+4Normal
8F45IEpithelial+4+3Normal
9M45IIIEpithelial+4+2Normal
10M69IIIBiphasic+4+2Normal
11M30IIEpithelial+2Normal
12F58IIIEpithelial+4+4Normal
13M50IIIEpithelial+4+4Acute Pnd
14M52IIIEpithelial+4+4RMHc+2+3
15M59IIIEpithelial+4+3Normal
16M63IIIEpithelial+2+3Hb
17F52IIIEpithelial+4+2Normal
18M63IIEpithelial+4+4Normal
19M62IIIEpithelial+2Normal
20M72IIIEpithelial+2+4RMH+2
21M68IIIEpithelial+3+4Normal
22F42IEpithelial+4Hb/OPne
23M65IIIEpithelial+4+4Normal
24M60IIIEpithelial+4+4Normal
25M65IIIBiphasic+4+4Normal
26M62IIEpithelial+4+4FB Rxnf
27F46IIISarcomatoid+4+4Normal
28M61IIIEpithelial+4+2Normal
29M76IIIBiphasic+4+2ATMH/MMg+2+4
30M59IIISarcomatoid+4+2Normal
  • Number scores were assigned according to criteria established by the College of American Pathologists as described in “Materials and Methods.”

  • H, hemorrhage.

  • RMH, reactive mesothelial hyperplasia.

  • Pn, pneumonia.

  • OPn, organizing pneumonia.

  • FB Rxn, foreign body reaction.

  • ATMH/MM, atypical mesothelial hyperplasia/malignant mesothelioma.

  • C-1, control lung sample.